Trials / Completed
CompletedNCT03794505
Quality of Life and Pain With Infiltration or Suprascapular Nerve Block in Glenohumeral Arthirtis
Health Related Quality of Life and Pain Managment Using Infiltration or Suprascapular Nerve Block Ultrasound Guided in Patients With Glenohumeral Arthirtis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Instituto Mexicano del Seguro Social · Other Government
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Efficacy in pain and health related quality of life of suprascapular nerve block ultrasound guided and glenohumeral infiltration in glenohumeral arthritis
Detailed description
To describe the efficacy in pain management and health related quality of life of suprascapular nerve block ultrasound guided and glenohumeral infiltration in patients with glenohumeral arthritis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methylprednisolone Acetate | depo-medrol 40 mg |
| DRUG | Lidocaine 2% Injectable Solution | 2ml of 2% lidocaine |
| DRUG | Ropivacaine HCl Inj 7.5 MG/ML | 25 mg |
Timeline
- Start date
- 2018-04-01
- Primary completion
- 2018-08-30
- Completion
- 2018-08-30
- First posted
- 2019-01-07
- Last updated
- 2019-01-08
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT03794505. Inclusion in this directory is not an endorsement.